Research Article

Related GMR Articles

Colorectal cancer; Meta-analysis; Polymorphism; XRCC3

Numerous studies have evaluated the relationship between the T241M polymorphism of the X-ray repair cross-complementing group 3 (XRCC3) gene and colorectal cancer (CRC) risk. However, the specific relationship remains controversial. We conducted meta-analysis to investigate the relationship between the XRCC3 T241M polymorphism and CRC risk. The PubMed and Embase ... more

L.Z. Zhang; Y.S. Li; H.Z. Liu
C677T; Colorectal cancer; Folate metabolism; Methylation; MTHFR; Polymorphisms

We evaluated methylenetetrahydrofolate reductase gene C677T polymorphisms in patients with colorectal cancer in a population-based case-control study in the Azerbaijan population. Genomic DNA was isolated from blood samples taken from 155 patients with colorectal cancer and 155 healthy individuals. The MTHFR gene C677T polymorphism was detected on agarose ... more

H. Aslanov; R. Agaev; B. Bayramov; A. Hadizade; N. Alakbarova; S. Abdulrahimli; V. Yagublu
Breast cancer; Chemotherapy response; GSTM1 polymorphism; Mexican population

The glutathione S transferase (GST) family plays an important role in the processing of carcinogens. Data on the null GSTM1 genotype has revealed associations with cancer, and has been suggested to affect carcinogen metabolism and to contribute to tumor promotion in the mammary gland. We examined the role of the null GSTM1 genotype by comparing the genotypes of 276 ... more

O. Soto-Quintana; G.M. Zúñiga-González; R. Ramírez-Patiño; A. Ramos-Silva; L.E. Figuera; D.I. Carrillo-Moreno; I.A. Gutiérrez-Hurtado; A.M. Puebla-Pérez; B. Sánchez-Llamas; M.P. Gallegos-Arreola
-238G>A; -308G>A; Colorectal cancer; Haplotype; Mexican population; TNF-α

The objective of this study was to examine the association between TNF-α serum levels and -308G>A and -238G>A polymorphisms in the corresponding gene by comparing healthy subjects to colorectal cancer (CRC) patients from a Mexican population. Serum levels of TNF-α were found to significantly differ between CRC patients and controls (P = 0.001), but no relationship between the -308G ... more

I.A. Gutiérrez-Hurtado; A.M. Puebla-Pérez; J.I. Delgado-Saucedo; L.E. Figuera; G.M. Zúñiga-González; K. Gomez-Mariscal; C.A. Ronquillo-Carreón; M.P. Gallegos-Arreola; I.A. Gutiérrez-Hurtado; A.M. Puebla-Pérez; J.I. Delgado-Saucedo; L.E. Figuera; G.M. Zúñiga-González; K. Gomez-Mariscal; C.A. Ronquillo-Carreón; M.P. Gallegos-Arreola
Colorectal cancer; Epithelial cell adhesion molecule; Immunohistochemistry

We investigated the relationship between the expression of epithelial cell adhesion molecule (EpCAM) and the occurrence and development of colon cancer. Fifty colon cancer tissues and adjacent normal tissues were collected, while 40 normal intestinal mucosa tissues were collected as the blank group. EpCAM expression was detected by immunohistochemistry and the patients were followed-up to ... more

X.B. Chai; R.F. Song; F. Xu
Biomarker; Colorectal cancer; Diagnostic marker; Meta-analysis; MicroRNA-29a

Previous studies have revealed that the expression level of microRNA-29a (miR-29a) was remarkably different in colorectal cancer (CRC) patients and healthy controls, indicating that miR-29a can be used as a diagnostic marker of CRC, but the results have been inconsistent. We conducted this meta-analysis to assess the diagnostic performance of blood-based miR-29a for CRC. We performed a ... more

M.L. Zhi; Z.J. Liu; X.Y. Yi; L.J. Zhang; Y.X. Bao
BRAFV600E mutation; Colorectal cancer; Histopathological criteria; KRAS mutations

KRAS and BRAF mutations are well-recognized molecular alterations during colorectal carcinogenesis, but there is little agreement on their effect on tumor characteristics. Therefore, we aimed to evaluate the distribution of the most common KRAS and BRAF mutations in Greek patients with colorectal cancer and their possible associations with clinical ... more

M. Samara; K. Kapatou; M. Ioannou; Ε. Kostopoulou; R. Papamichali; C. Papandreou; A. Athanasiadis; G. Koukoulis
Angiopoietin-2; Colorectal cancer; Diagnostic biomarker

We examined the expression of angiopoietin-2 in serum samples from patients diagnosed with colorectal cancer and healthy volunteers and investigated the feasibility of using angiopoietin-2 as a potential diagnostic colorectal cancer biomarker. Enzyme-linked immunosorbent assays were used to measure the levels of angiopoietin-2 in patients with colorectal cancer and healthy control subjects. ... more

Z.Q. Wang; X.L. Sun; H.L. Su; X.F. Liu; Y.J. Xuan; S.Q. Yu
Colorectal cancer; Meta-analysis; Non-metastatic protein 23; Pathological characteristics; Prognosis

The current meta-analysis was performed to investigate the association between non-metastatic protein 23 (NM23) expression, tumor pathology, and disease prognosis in colorectal cancer (CRC) among Asians. English and Chinese language-based electronic databases (e.g., PubMed, EBSCO, Ovid, Springerlink, Wiley, Web of Science, Wanfang databases, China National Knowledge Infrastructure, VIP ... more

J.W. Fu; X.Q. Chu
Adenocarcinoma; Colorectal cancer; GA733 family; RT-PCR

GA733-1/-2/-3 genes have been detected in various types of cancer, although their role has not been fully clarified. GA733-2 and GA733-1 have been correlated with lymph node metastases in laryngeal cancer and liver metastases, respectively. Only a few studies have elucidated the mechanisms regulating GA733-1/-2 expression and their effect on colorectal cancer. ... more

I. Mamaloudis; D. Zacharoulis; M. Samara; G. Papadopoulos; S. Samara; G. Koukoulis; C. Chatzitheofilou; P. Kollia